| 000 | 01556 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513103920.0 | ||
| 264 | 0 | _c19970325 | |
| 008 | 199703s 0 0 eng d | ||
| 022 | _a1042-8194 | ||
| 024 | 7 |
_a10.3109/10428199609067585 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTari, A | |
| 245 | 0 | 0 |
_aLiposomal delivery of oligodeoxynucleotides. _h[electronic resource] |
| 260 |
_bLeukemia & lymphoma _cMar 1996 |
||
| 300 |
_a93-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 |
_aBone Marrow _xdrug effects |
| 650 | 0 | 4 | _aBone Marrow Cells |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aDrug Carriers |
| 650 | 0 | 4 | _aExons |
| 650 | 0 | 4 |
_aFusion Proteins, bcr-abl _xgenetics |
| 650 | 0 | 4 | _aHL-60 Cells |
| 650 | 0 | 4 |
_aHematopoietic Stem Cells _xcytology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntracellular Fluid _xmetabolism |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
| 650 | 0 | 4 |
_aLeukocytes, Mononuclear _xdrug effects |
| 650 | 0 | 4 | _aLiposomes |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 |
_aOligonucleotides, Antisense _xadministration & dosage |
| 650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
| 650 | 0 | 4 |
_aThionucleotides _xadministration & dosage |
| 700 | 1 | _aKhodadadian, M | |
| 700 | 1 | _aEllerson, D | |
| 700 | 1 | _aDeisseroth, A | |
| 700 | 1 | _aLopez-Berestein, G | |
| 773 | 0 |
_tLeukemia & lymphoma _gvol. 21 _gno. 1-2 _gp. 93-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/10428199609067585 _zAvailable from publisher's website |
| 999 |
_c8899792 _d8899792 |
||